Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors
<p>Abstract</p> <p>Recently, there is considerable interest in the field of anti-HIV therapy to identify and develop chromatin-modifying histone deacetylase (HDAC) inhibitors that can effectively reactivate latent HIV in patients. The hope is that this would help eliminate cells ha...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-08-01
|
| Series: | Virology Journal |
| Online Access: | http://www.virologyj.com/content/8/1/400 |